Urodylatyna - natriuretyczny peptyd syntetyzowany w nerkach

• Autorzy: Dratwa A

Warianty tytułu

EN

Urodilatin - a natriuretic peptide synthesized in kidney

• Języki publikacji: PL

Abstrakty

EN

Urodilatin is a natriuretic peptide member of the A-type natriuretic peptide family which has been isolated from urine. This paracrine hormone is secreted in the distal tubules and acts on luminal receptors of collecting duct cells. Urodilatin plays an important role in the regulation of body fluid volume and electrolyte balance. It inhibits water and sodium resorption in the collecting ducts by interaction with guanylyl cyclase-coupled receptor A, the same receptor by which atrial natriuretic peptide acts. The result of urodilatin action is the increase of natriuresis and diuresis.

Słowa kluczowe

PL

receptory; dzialanie; wydzielanie; fizjologia zwierzat; synteza; peptydy natriuretyczne; urodylatyna

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2007
• Tom: 63
• Numer: 01
• Opis fizyczny: s.41-43,rys.,bibliogr.

Twórcy

autor

Dratwa A

• Akademia Rolnicza, ul.Doktora Judyma 6, 71-466 Szczecin

Bibliografia

• 1. Abassi Z. A., Powell J. R., Golomb E., Keiser H. R.: Renal and systemic effects of urodilatin in rats with high-output heart failure. Am. J. Physiol. 1992, 262, F615-621.
• 2. Anand-Srivastava M. B.: Natriuretic peptide receptor-C signaling and regulation. Peptides 2005, 26, 1044-1059.
• 3. Baxter G. F.: The natriuretic peptides. Basic Res. Cardiol. 2004, 99, 71-75.
• 4. Bełtowski J., Górny D., Marciniak A.: The mechanism of Na⁺, K⁺-ATPase inhibition by atrial natriuretic factor in rat renal medulla. J. Physiol. Pharmacol. 1998, 49, 271-283.
• 5. Bestle M. H., Olsen N. V., Christensen P., Jensen B. V., Bie P.: Cardiovascular, endocrine, and renal effects of urodilatin in normal humans. Am. J. Physiol. 1999, 276, R684-695.
• 6. Bub A., Rechkemmer G., Hock D., Forssmann W. G.: Urodilatin secretion in salt-loaded Wistar rats. Eur. J. Med. Res. 1996, 25, 417-424.
• 7. Buckley M. G., Sagnella G. A., Markandu N. D., Singer D. R., MacGregor G. A.: Concentrations of N-terminal ProANP in human plasma: evidence for ProANP (1-98) as the circulating form. Clin. Chim. Acta 1990, 191, 1-14.
• 8. Carstens J., Jensen K. T., Pedersen E. B.: Effect of urodilatin infusion on renal haemodynamics, tubular function and vasoactive hormones. Clin. Sci. (Lond). 1997, 92, 397-407.
• 9. Carstens J., Jensen K. T., Pedersen E. B.: Metabolism and action of urodilatin infusion in healthy volunteers. Clin. Pharmacol. Ther. 1998, 64, 73-86.
• 10. Dorner G. T., Selenko N., Kral T., Schmetterer L., Eichler H. G., Wolzt M.: Hemodynamic effects of continuous urodilatin infusion: a dose-finding study. Clin. Pharmacol. Ther. 1998, 64, 322-330.
• 11. Dratwa A.: Przedsionkowy peptyd natriuretyczny - ANP. Medycyna Wet. 2002, 58, 108-111.
• 12. Drummer C., Franck W., Heer M., Forssmann W. G., Gerzer R., Goetz K.: Postprandial natriuresis in humans: further evidence that urodilatin, not ANP, modulates sodium excretion. Am. J. Physiol. 1996, 270, F301-310.
• 13. Emmeluth C., Drummer C., Gerzer R., Bie P.: Natriuresis in conscious dogs caused by increased carotid (Na+) during angiotensin II and aldosterone blockade. Acta Physiol. Scand. 1994, 151, 403-411.
• 14. Endlich K., Forssmann W. G., Steinhausen M.: Effects of urodilatin in the rat kidney: comparison with ANF and interaction with vasoactive substances. Kidney Int. 1995, 47, 1558-1568.
• 15. Gagelmann M., Hock D., Forssmann W. G.: Urodilatin (CDD/ANP-95-126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (alpha-hANP/CDD-99-126). FEBS Lett. 1988, 233, 249-254.
• 16. Goetz K., Drummer C., Zhu J. L., Leadley R., Fiedler F., Gerzer R.: Evidence that urodilatin, rather than ANP, regulates renal sodium excretion. J. Am. Soc. Nephrol. 1990, 1, 867-874.
• 17. Heringlake M., Bahlmann L., Klaus S., Wagner K., Schmucker P., Pagel H.: Effects of angiotensin II and the AT(1) receptor antagonist losartan on the renal excretion of urodilatin. Kidney Blood Press. Res. 2001, 24, 79-83.
• 18. Heringlake M., Klaus S., Bahlmann L., Sehested J., Pagel H., Schmucker P.: Effects of posture and positive airway pressure on plasma atrial natriuretic peptide and renal urodilatin excretion. Clin. Nephrol. 2001, 56, 364-369.
• 19. Heringlake M., Wagner K., Schumacher J., Pagel H.: Urinary excretion of urodilatin is increased during pressure natriuresis in the isolated perfused rat kidney. Am. J. Physiol. 1999, 277, F347-351.
• 20. Herten M., Lenz W., Gerzer R., Drummer C.: The renal natriuretic peptide urodilatin is present in human kidney. Nephrol. Dial. Transplant. 1998, 13, 2529-2535.
• 21. Hildebrandt D. A., Mizelle H. L., Brands M. W., Hall J. E.: Comparison of renal actions of urodilatin and atrial natriuretic peptide. Am. J. Physiol. 1992, 262, R395-399.
• 22. Hirsch J. R., Kruhoffer M., Adermann K., Heitland A., Maronde E., Meyer M., Forssmann W. G., Herter P., Plenz G., Schlatter E.: Cellular localization, membrane distribution, and possible function of guanylyl cyclases A and 1 in collecting ducts of rat. Cardiovasc. Res. 2001, 51, 553-561.
• 23. Kentsch M., Ludwig D., Drummer C., Gerzer R., Muller-Esch G.: Haemodynamic and renal effects of urodilatin in healthy volunteers. Eur. J. Clin. Invest. 1992, 22, 319-325.
• 24. Koike J., Nonoguchi H., Terada Y., Tomita K., Marumo F.: Effect of urodilatin on cGMP accumulation in the kidney. J. Am. Soc. Nephrol. 1993, 3, 1705-1709.
• 25. Nagase M., Katafuchi T., Hirose S., Fujita T.: Tissue distribution and localization of natriuretic peptide receptor subtypes in stroke-prone spontaneously hypertensive rats. J. Hypertens. 1997, 15, 1235-1243.
• 26. Meyer M., Richter R., Brunkhorst R., Wrenger E., Schulz-Knappe P., Kist A., Mentz P., Brabant E. G., Koch K. M., Rechkemmer G., Forssmann W. G.: Urodilatin is involved in sodium homeostasis and exerts sodium-state-dependent natriuretic and diuretic effects. Am. J. Physiol. 1996, 271, F489-497.
• 27. Rutherford R. A. D., Matsuda Y., Wilkins M. R., Polak J. M., Wharton J.: Identification of renal natriuretic peptide receptor subpopulations by use of the non-peptide antagonist, HS-142-1. Br. J. Pharmacol. 1994, 113, 931-939.
• 28. Saxenhofer H., Raselli A., Weidmann P., Forssmann W. G., Bub A., Ferrari P., Shaw S. G.: Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men. Am. J. Physiol. 1990, 259, F832-838.
• 29. Schermuly R. T., Weissmann N., Enke B., Ghofrani H. A., Forssmann W. G., Grimminger F., Seeger W., Walmrath D.: Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplication. Am. J. Respir. Cell Mol. Biol. 2001, 25, 219-225.
• 30. Schulz-Knappe P., Forssmann K., Herbst F., Hock D., Pipkorn R., Forssmann W. G.: Isolation and structural analysis of "urodilatin", a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin. Wochenschr. 1988, 66, 752-759.
• 31. Schulz-Knappe P., Honrath U., Forssmann W. G., Sonnenberg H.: Endogenous natriuretic peptides: effect on collecting duct function in rat kidney. Am. J. Physiol. 1990, 259, F415-418.
• 32. Scavone C., Scanlon C., McKee M., Nathanson J. A.: Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase. J. Pharmacol. Exp. Ther. 1995, 272, 1036-1043.
• 33. Semmekrot B., Roseau S., Vassent G., Butlen D.: Developmental patterns of renal atrial natriuretic peptide receptors: (125I) alpha-rat atrial natriuretic peptide binding in glomeruli and inner medullary collecting tubules microdissected from kidneys of young rats. Mol. Cell. Endocrinol. 1990, 68, 35-43.
• 34. Valentin J. P., Sechi L. A., Qui C., Schambelan M., Humphreys M. H.: Urodilatin binds to and activates renal receptors for atrial natriuretic peptide. Hypertension. 1993, 21, 432-438.
• 35. Vasely D. L., Overton R. M., Blankenship M., McCormick M. T., Schocken D. D.: Atrial natriuretic peptide increases urodilatin in the circulation. Am. J. Nephrol. 1998, 18, 204-213.
• 36. Watenpaugh D. E., Pump B., Bie P., Norsk P.: Does gender influence human cardiovascular and renal responses to water immersion? J. Appl. Physiol. 2000, 89, 621-628.